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ECM remodeling (Cox and Helvering, 
2006) and wound healing (Ashcroft et 
al., 2003; Mills et al., 2005). It has been 
postulated that striae may result from 
an exaggerated wound healing process 
(Pinkus et al., 1966), and, clinically — 
in pregnancy at least — the severity of 
striae appears to be related to a younger 
maternal age, although the age of onset 
of striae was not recorded by Salter et 
al. (2006). Of further interest is a signifi-
cantly higher occurrence of varicosities 
in those individuals also presenting with 
striae (Salter et al., 2006). It is plausible 
that these phenomena describe a gener-
alized deterioration of ECM structures 
that could result from a number of bio-
logical events.
The study by Salter et al. (2006) pre-
sents an appealing relationship between 
the occurrence of skin striae and pelvic 
relaxation. It will be interesting to see 
whether prospective studies in this area 
can confirm whether clinical dermato-
logical examination can identify, and 
therefore target therapy to, individuals at 
risk of prolapse in later life.
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Signaling Downstream of p38 in 
Psoriasis
J. Simon C. Arthur1 and Joanne Darragh1
Psoriasis is an inflammatory skin disease characterized by infiltration of the skin 
by T cells and increased production of pro-inflammatory cytokines. Two recent 
reports show that the p38-activated kinases mitogen-activated protein kinase-
activated protein kinase 2 and mitogen- and stress-activated protein kinase 
are activated in psoriatic skin and may contribute to the production of pro-
inflammatory cytokines.
Journal of Investigative Dermatology (2006) 126, 1689–1691. doi:10.1038/sj.jid.5700280
Psoriasis is a common skin disorder, and 
estimates of its prevalence vary from 
0.5% to 4.6% of the world population. 
A significant proportion of patients may 
also exhibit psoriatic arthritis, although 
the onset of arthritis can precede the 
development of psoriasis. Psoriasis is 
an inflammatory disorder that is char-
acterized by epidermal hyperplasia, 
increases in keratin expression, and 
recruitment of T cells as well as changes 
in the endothelial vascular system (Bos 
et al., 2005; Bowcock and Krueger, 
2005; Krueger and Ellis, 2005). On the 
basis of the analysis of the cytokines 
produced, psoriasis is often considered 
to be a T-helper 1 condition, as levels of 
IFN-γ, tumor necrosis factor (TNF), IL-
1, IL-2, IL-6, and IL-8 are increased in 
psoriatic lesions. The recruitment of T 
cells is likely to be critical to the devel-
opment of the disease; however, the 
immunology of psoriasis is complex, 
and several other cell types, including 
dendritic cells, phagocytes, and kera-
tinocytes, are also likely to play a role 
(Bos et al., 2005; Bowcock and Krueger, 
2005; Krueger and Ellis, 2005).
Recent advances in treatment have 
confirmed a role for T cells in psoriasis, 
and agents that target T cells, such as 
alefacept and efalizumab, have been 
shown to reduce the symptoms of pso-
riasis. Interestingly, anti-TNF therapies 
have also proved effective at treating 
psoriasis, demonstrating a critical role 
for this cytokine in the condition (Bos et 
al., 2005; Bowcock and Krueger, 2005; 
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At least two of these 
downstream kinases, 
MAPKAP-K2 and MSK1, 
are activated in psoriatic 
skin.
Krueger and Ellis, 2005). The source of 
TNF in psoriasis is, however, unclear, as 
several cell types, including both T cells 
and keratinocytes, have the potential to 
produce TNF in the skin. The signaling 
pathways that mediate both the produc-
tion and the pathological effects in psori-
atic skin are also not clearly defined.
Mitogen-activated protein kinases 
(MAPKs) form a series of conserved sig-
naling networks in mammalian cells 
(Roux and Blenis, 2004). Four main 
groups of MAPKs have been identi-
fied: the classical MAPKs extracellular 
signal-regulated kinase 1 (ERK1) and 
ERK2; c-Jun N-terminal kinases (JNKs); 
p38 MAPKs; and atypical MAPKs such 
as ERK5 and ERK3. Of these, both the 
ERK1/2 and p38 MAPK cascades have 
been implicated in the production of 
TNF, and, in addition, these cascades 
are also activated in many cell types in 
response to TNF signaling. p38 MAPKs 
have also attracted particular interest in 
the immune system, as p38 was origi-
nally identified as the cellular target of 
a group of drugs that inhibited pro-
inflammatory cytokine production in 
response to lipopolysaccharide. This has 
led several companies to develop and 
patent p38 inhibitors as potential treat-
ments for several inflammatory diseases, 
including arthritis and psoriasis.
Analysis of psoriatic skin has shown 
that the levels of both ERK1/2 and p38 
activity are increased, which is consistent 
with a potential role for these kinases in 
the development of psoriasis (Johansen 
et al., 2005). Both the ERK1/2 and p38 
MAPK cascades are able to activate 
additional downstream kinases: ERK1/2 
activates ribosomal S6 kinase, p38α acti-
vates MAPKAP-K2, and both ERK1/2 and 
p38α are able to activate mitogen- and 
stress-activated protein kinase 1 (MSK1) 
and MSK2 (Roux and Blenis, 2004). Two 
recent reports have now also shown that 
at least two of these downstream kinases, 
MAPKAP-K2 and MSK1, are activated in 
psoriatic skin.
Studies on MAPKAP-K2 knock-
out mice have identified a role for this 
kinase in the production of some pro-
inflammatory cytokines in response to 
lipopolysaccharide, notably TNF, IL-6, 
IL-1β, and IFN-γ (Kotlyarov et al., 1999). 
Levels of these cytokines in MAPKAP-
K2 knockout mice were significantly 
decreased as compared with those in 
wild-type controls in response to lipo-
polysaccharide. MAPKAP-K2 is thought 
to control cytokine production at a post-
transcriptional level, both via the regula-
tion of RNA stability, as happens for IL-6, 
and by control of protein translation, as 
occurs for TNF (Kotlyarov et al., 1999; 
Neininger et al., 2002). In a recent paper 
in the Journal of Immunology, Johansen 
et al. (2006) have shown that TNF protein 
levels, but not those of the TNF mRNA, 
are increased in psoriatic skin. The lev-
els of MAPKAP-K2 activity, as judged by 
phospho-blotting, were also increased 
in psoriatic skin, suggesting a possible 
mechanism for the elevated TNF levels. 
Consistent with this, it was found that 
small interfering RNA (siRNA)-mediated 
knockdown of MAPKAP-K2 reduced the 
production of TNF in primary keratino-
cytes stimulated with IL-1β (Johansen et 
al., 2006). It would therefore be of inter-
est to see whether knockout of MAPKAP-
K2 results in a protective effect in mouse 
models of skin inflammation.
MSK1, and the related kinase MSK2, 
are nuclear kinases activated downstream 
of both ERK1/2 and p38α (Darragh et al., 
2005). Double knockouts of both MSK1 
and MSK2 are viable (Wiggin et al., 
2002) and do not exhibit an overt pheno-
type. Cells from these mice have, how-
ever, established a role for these kinases 
in the mitogen- and stress-induced phos-
phorylation of the transcription factors 
cAMP-response element-binding protein 
(CREB) and activation transcription fac-
tor 1 and the chromatin proteins histone 
H3 and HMG-14 (Soloaga et al., 2003; 
Wiggin et al., 2002). Downstream of 
this, it has been shown that MSKs con-
tribute to the induction of some immedi-
ate early genes, including c-fos, nur77, 
and nor1 (Darragh et al., 2005). The role 
of MSK has not, however, been specifi-
cally addressed in the immune system 
of these mice. In a paper in this issue of 
the Journal of Investigative Dermatology, 
Funding et al. (2006) demonstrate that 
MSK1 activity, as judged by phospho-
blotting, is increased in psoriatic com-
pared with normal skin. Immunostaining 
experiments suggested that this activa-
tion of MSK occurred mainly in keratino-
cytes in the psoriatic skin.
Using primary keratinocytes, Funding 
et al. (2006) further show that IL-1β 
activates p38α, which in turn activates 
MSK1, leading to CREB phosphoryla-
tion. Consistent with the work in knock-
out mice, siRNA-mediated knock-down 
of MSK1 resulted in decreased CREB 
phosphorylation. Given the activation 
of MSK1 in psoriatic skin, it would be 
of interest for future work to determine 
whether CREB phosphorylation is also 
increased in psoriatic skin. The siRNA 
knock-down of MSK1 also resulted in 
modest decreases in IL-6 and IL-8 pro-
duction. Interestingly, a role for MSK1 in 
IL-6 transcription in fibroblasts has been 
suggested previously. Specifically, MSK 
was suggested to act either upstream 
of NF-κB or by inducing chromosomal 
remodeling at the IL-6 locus (Vermeulen 
et al., 2003). Although the reduction 
in cytokine production in the study by 
Funding et al. (2006) was modest, it is 
worth noting that only MSK1 was tar-
geted by siRNA. Evidence from knock-
out mice has suggested that in most 
cell types MSK1 and MSK2 are able to 
functionally compensate for each other, 
and therefore knockout of both isoforms 
would be needed to show the maximal 
effect on cytokine production (Wiggin et 
al., 2002). Future work to address the role 
of MSKs in cytokine production, possibly 
using gene-targeted mice, would there-
fore be very interesting.
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Plenty New Under the Sun
Jonathan Rees1
Variation at the melanocortin 1 receptor (MC1R) is very common in most non-
African world populations. A range of variants predispose to skin cancer, including 
melanoma. What remains unclear are the mechanisms linking gene variation with 
sun sensitivity or tumor risk. In particular, it remains unclear whether pigmentary 
effects of the MC1R can account for all of the increase in cancer risk.
Journal of Investigative Dermatology (2006) 126, 1691–1692. doi:10.1038/sj.jid.5700345
The modern study of the genetics of 
normal human pigmentary variation is 
just over ten years old (Rees, 2003). The 
field may not yet be mature, but there 
is a clear feeling that the first few chap-
ters of this particular story can now be 
written: in broad outline we now know 
which genes account for most variation 
in human skin and hair color. The paper 
by Stratigos and colleagues (2006, this 
issue), in which melanocortin 1 recep-
tor (MC1R) variants have been studied 
in relation to pigmentary phenotype and 
melanoma, is a welcome addition to the 
literature — welcome, because most 
previous studies of pigmentary genetics 
have concentrated on northern rather 
than southern European populations, 
and because the paper highlights some 
of the uncertainties in our understand-
ing of the mechanisms by which MC1R 
variation affects phenotype.
The first modern study of the genet-
ics of red hair was carried out almost a 
century ago by the Davenports at what 
was then the Carnegie Institute and is 
now famous worldwide as Cold Spring 
Harbor Laboratory (reviewed by Rees, 
2003). The Davenports studied kindreds 
with red hair and suggested that the red-
hair trait approximated to an autosomal 
recessive. They were right, although not 
all subsequent work came to the same 
conclusion. The next seminal advance, 
following a few unsuccessful attempts 
at mapping the red-hair trait in humans, 
came from the marriage of mouse and 
molecular genetics. The genes underly-
ing a range of murine coat-color muta-
tions were cloned, and within years the 
genetic bases for some rare mendelian 
pigmentary syndromes in humans were 
identified. One gene, the melanocortin 
1 receptor, the subject of the study by 
Stratigos et al. (2006), was cloned in mice 
by Roger Cone’s group in 1993 (Robbins 
et al., 1993). Work in mice showed that 
signaling through this pathway led to an 
increase in the ratio of eumelanin to phe-
omelanin in hair (Robbins et al., 1993). 
Conversely, the absence of, or a reduc-
tion in, signaling, whether due to muta-
tion at the mc1r or absence of the ligand 
α-melanocyte-stimulating hormone, 
resulted in a relative overproduction of 
pheomelanin, leading to a yellow coat.
Shortly after Cone and colleagues’ 
work in mice, it was reported that most 
red-haired persons harbored homo-
zygous diminished-function alleles at 
the MC1R (Valverde et al., 1995). The 
human MC1R codes for a 317-amino 
acid G-coupled receptor, and many 
non-African human populations show a 
striking degree of variation at this locus 
(Wong and Rees, 2005). Over 75 differ-
ent MC1R alleles in humans have been 
identified (Wong and Rees, 2005), and 
Stratigos et al. (2006) show that even in 
a southern European population 38% 
of the control population shows MC1R 
variants. A striking feature of the MC1R 
is that a large number of the alleles 
appear to be quantitatively different in 
terms of function; that is, rather than all 
the alleles associated with red hair being 
complete loss-of-function alleles, they 
show varying degrees of signaling activ-
ity (Ringholm et al., 2004). Given that 
there is evidence for a clear additive (or 
dosage) effect among 0, 1, and 2 variant 
alleles, a range of physiological activ-
ity can arise from a single locus. MC1R 
heterozygotes are intermediate for hair 
eumelanin and pheomelanin ratios, and 
those with different shades of red hair 
appear to differ at the MC1R (Naysmith 
et al., 2004). Thus, although red hair 
approximates to an autosomal reces-
sive trait, the more closely one stud-
ies the phenotype, the more subtle the 
relation between particular alleles and 
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